A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)

Clinical trial NCT01673659 · COMPLETED

Trial details

NCT number: NCT01673659
Sponsor: Padagis LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2012-08-01
Primary completion: 2012-10-01
Enrollment: 1220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.